FindTrial
Sign In

A combination of Triamcinolone Acetonide 5 fluorouracil and Verapamil injection for treatment of keloid in adults

A combination of Triamcinolone Acetonide 5 Fluorouracil 5 FU and Verapamil intralesional injection for treatment of Keloid in adults An Interventional Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073176
Enrollment
31
Registered
2024-09-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L91- Hypertrophic disorders of skin

Interventions

Intervention1: Intralesional injection of a combination of Triamcinolone Acetonide (40 mg/ml), 5 FU (50mg/ml), and Verapamil(2.5mg/ml): Each patient will undergo a detailed history review, including d

Sponsors

YCM Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients having keloid and willing to give a consent 2) Age group above 18 years

Exclusion criteria

Exclusion criteria: 1) Secondary infection of keloid 2) Patients having blood dyscrasias

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of combination of Triamcinolone Acetonide, 5-Fluorouracil(5-FU) and Verapamil intralesional injection therapy in the treatment of keloid , employing the Patient and Observer Scar Assessment Scale (POSAS)Timepoint: 18 months—

Secondary

MeasureTime frame
To study the adverse effects following the injection .Timepoint: 18 months—

Countries

India

Contacts

Public ContactDr Nachiket Palaskar

YCM hospital

nachiketpalaskar@gmail.com9422349134

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 9, 2026